FDA panel endorses lower-dose Moderna COVID shot for booster
Experts recommended a booster shot for seniors, as well as younger adults with conditions
October 15, 2021
U.S. health advisers said Thursday that some Americans who received Moderna's COVID-19 vaccine at least six months ago should get a half-dose booster to rev up protection against the coronavirus.
The panel of outside advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, as well as younger adults with other health problems, jobs or living situations that put them at increased risk from COVID-19.
The recommendation is non-binding but it's a key step toward expanding the U.S. booster campaign to millions more Americans. Many people who got their initial Pfizer shots at least six months ago are already getting a booster after the FDA authorized their use last month - and those are the same high-risk groups that FDA's advisers said should get a Moderna booster.